Peter Palese | |
---|---|
Nationality | United States |
Fields |
Microbiology Virology |
Institutions | Icahn School of Medicine at Mount Sinai |
Alma mater | University of Vienna |
Notable awards | Member of the National Academy of Sciences Robert Koch Prize (2006) European Virology Award (EVA) |
Peter Palese is a United States microbiologist and Professor and Chair of the Department of Microbiology at the Icahn School of Medicine at Mount Sinai in New York City, and an expert in the field of RNA viruses.
Palese built "the first genetic maps for influenza A, B and C viruses, identified the function of several viral genes, ...defined the mechanism of neuraminidase inhibitors (which are now FDA-approved antivirals)" and "pioneered the field of reverse genetics for negative-strand RNA viruses". Furtherance of this technique has been used by Palese and his colleagues in reconstructing and studying the pathogenicity of the extinct but deadly 1918 pandemic influenza virus. Reverse genetics also assist in the development of new flu vaccines.
Palese is the author of multiple book chapters and more than 400 scientific publications. He is on the editorial board for Proceedings of the National Academy of Sciences of the United States of America (PNAS). He has been awarded multiple patents on viral vaccines and antivirals.
Palese received his Ph.D. in chemistry in 1969 and his M.S. In pharmacy in 1970 from the University of Vienna. He was a postdoctoral fellow at the Roche Institute of Molecular Biology from 1970 until 1971, when he joined the Department of Microbiology at the Icahn School of Medicine at Mount Sinai as Assistant Professor. In 1976 he was Visiting Associate Professor, Department of Microbiology and Immunology at the University of California, Los Angeles School of Medicine. In 1987 he was named Chairman of the Department of Microbiology of the Icahn School of Medicine at Mount Sinai.